Download presentation
Presentation is loading. Please wait.
Published byMaximillian Neil Carter Modified over 6 years ago
1
Volume 73, Pages S131-S136 (April 2008)
Amino-acid-based peritoneal dialysis solution improves amino-acid transport into skeletal muscle M. Asola, K. Virtanen, K. Någren, S. Helin, M. Taittonen, H. Kastarinen, B. Anderstam, J. Knuuti, K. Metsärinne, P. Nuutila Kidney International Volume 73, Pages S131-S136 (April 2008) DOI: /sj.ki Copyright © 2008 International Society of Nephrology Terms and Conditions
2
Figure 1 A transverse section of the femoral region. Black ovals denote the regions of interest. Kidney International , S131-S136DOI: ( /sj.ki ) Copyright © 2008 International Society of Nephrology Terms and Conditions
3
Figure 2 The AA uptake into skeletal muscle with both dialysis solutions in the fasting state and during insulin stimulation (clamp). The uptake of all AAs was significantly higher during AA dialysis solution than glucose-based solution, during both fasting and insulin stimulation. In system A AAs, the uptake in the fasting condition was significantly higher when AA solution was used than during glucose-based solution, and there was a trend toward a higher uptake during insulin stimulation when AA solution was used. All AAs, sum of concentrations of all AAs; sysA, sum of concentrations of six AAs that typically use system A for their transport; G, treatment with glucose-based solution; AA, treatment with AA-based solution. Kidney International , S131-S136DOI: ( /sj.ki ) Copyright © 2008 International Society of Nephrology Terms and Conditions
4
Figure 3 Plasma AA concentrations with both dialysis solutions in the fasting state and during insulin stimulation (clamp). The concentrations of both AA groups were significantly higher during AA dialysis solution than glucose-based solution, during both fasting and insulin stimulation. All AAs, sum of concentrations of all AAs; sysA, sum of concentrations of six AAs that typically use system A for their transport; G, treatment with glucose-based solution; AA, treatment with AA-based solution. Kidney International , S131-S136DOI: ( /sj.ki ) Copyright © 2008 International Society of Nephrology Terms and Conditions
5
Figure 4 Study design. G, glucose-based dialysis fluid; N, 1.1% AA dialysis fluid. Kidney International , S131-S136DOI: ( /sj.ki ) Copyright © 2008 International Society of Nephrology Terms and Conditions
6
Figure 5 PET scans. The arrows denote the time of intravenous injections of positron-emitting tracer [11C]MeAIB. The hatched rectangles denote the time period of dynamic scanning. Kidney International , S131-S136DOI: ( /sj.ki ) Copyright © 2008 International Society of Nephrology Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.